Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

Origins Insights Offering Explained

Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but...

Origins – The Patient Focused Specialists

- PMLiVE

Medscape Expands Global Reach with Acquisition of Health Information Platform Grupo SANED

WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it has acquired Grupo SANED, Spain's leader in...

Medscape Education

- PMLiVE

FlyPharma Europe, Vienna: 2023 conference officially launched

The event will be held in the Vienna AirportCity, Office Park 4, from 10-11 October

Applying Vibrotactile Stimulation to Improve Parkinson’s

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Impetus Digital

- PMLiVE

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

There are no FDA approved vaccines for EBV, one of the most common human viruses

- PMLiVE

Eli Lilly/Boehringer’s Jardiance for children with type 2 diabetes accepted by FDA

The incidence of type 2 diabetes in children has nearly doubled over the past two decades

- PMLiVE

Chiesi Group and Affibody AB partner on respiratory disease treatments

The companies will progress up to three programmes against undisclosed target

- PMLiVE

Janssen’s single tablet combination shows promise in phase 3 PAH study

Around 500 to 1,000 cases of pulmonary arterial hypertension are diagnosed each year in the US

- PMLiVE

JCVI recommends spring COVID-19 booster for those at highest risk

Eligible individuals will be offered the booster around six months after their previous dose

- PMLiVE

Novo Nordisk’s weight-loss drug recommended by NICE

The drug, semaglutide, will be offered to eligible adults for a maximum of two years

Mednet Group is a certified woman-owned business

International Women’s Day – Why Being a Woman-Led Business Matters

For International Women's Day, we're exploring why it's so important that we see more female leaders taking charge.

Mednet

protraint of older woman with brain activity on grey background and text thinking creatively about patient involvement in publications

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Bedrock Healthcare Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links